Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30055939HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055940HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055941HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS20040704HPVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS44043072HTLV-1ENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS44048213HTLV-1ENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS44048233HTLV-1ENSG00000186951.17protein_codingPPARANoNo5465Q07869
TCGA Plot Options
Drug Information
GenePPARA
DrugBank IDDB01118
Drug NameAmiodarone
Target IDBE0000071
UniProt IDQ07869
Regulation Typeagonist
PubMed IDs24489787; 15265979
CitationsSzalowska E, van der Burg B, Man HY, Hendriksen PJ, Peijnenburg AA: Model steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slices. PLoS One. 2014 Jan 29;9(1):e86795. doi: 10.1371/journal.pone.0086795. eCollection 2014.@@McCarthy TC, Pollak PT, Hanniman EA, Sinal CJ: Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation. J Pharmacol Exp Ther. 2004 Dec;311(3):864-73. doi: 10.1124/jpet.104.072785. Epub 2004 Jul 20.
GroupsApproved; Investigational
Direct ClassificationAryl-phenylketones
SMILESCCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
PathwaysAmiodarone Action Pathway
PharmGKBPA448383
ChEMBLCHEMBL633